Stocks on the move: CRM, INTU, WFC >>> READ MORE

4 Biotech Stocks to Buy

When the market environment gets ugly (like now), biotech tends to become a safe-haven

      View All  

Biocryst Pharmaceutical (BCRX)

BCRX stock

If nothing else, Biocryst Pharmaceutical (BCRX) is a compelling biotech stock trade right now because of its short-squeeze potential. Per numbers reported just a few days ago, the short interest on BCRX had cranked up to an incredible 39.9% of the float. That’s a pretty risky bet — perhaps even flat out bad one — against a biotech stock that has zig-zagged its way to a 700% gain over the past thirteen months, not to mention looks like it’s gunning for another new high.

Oddly, high short interest isn’t the only reason a trader would want to add BCRX stock to a short list of biotech stocks to buy at this point, however. There’s also plenty of old-fashioned reason to step into a position here. See, while Biocryst Pharmaceutical isn’t working on an earth-shattering cure for cancer, its antiviral technology shows great promise as a treatment for angiodema and influenza. The company has even set its sights on Ebola.

While there are no specific catalysts in the hopper, BCRX stock has proven itself as one of the market’s favorites. That’s not a train you want to step in front of.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC